Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges: 2019-2024

Historic Amortization of Deferred Charges for Amphastar Pharmaceuticals (AMPH) over the last 6 years, with Dec 2024 value amounting to $6.0 million.

  • Amphastar Pharmaceuticals' Amortization of Deferred Charges rose 18.95% to $885,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 60.92%. This contributed to the annual value of $6.0 million for FY2024, which is 47.08% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Amortization of Deferred Charges of $6.0 million as of FY2024, which was down 47.08% from $11.4 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $11.4 million for FY2023, and its period low was $219,000 during FY2021.
  • For the 3-year period, Amphastar Pharmaceuticals' Amortization of Deferred Charges averaged around $6.0 million, with its median value being $6.0 million (2024).
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first crashed by 94.00% in 2021, then spiked by 2,346.14% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Amortization of Deferred Charges stood at $3.7 million in 2020, then slumped by 94.00% to $219,000 in 2021, then skyrocketed by 112.79% to $466,000 in 2022, then skyrocketed by 2,346.14% to $11.4 million in 2023, then plummeted by 47.08% to $6.0 million in 2024.